Showing results (141-150 of 331) with videos related to

Sort By:
Pageof 34
Science (New York, N.Y.)|April 16, 2026
Sex effects on gene expression across the human cerebral cortex at cell type resolutionAlex R DeCasien, Pavan Auluck, Siyuan Liu, et al.
Cellular and Molecular Life Sciences : CMLS|November 25, 2019
Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's diseaseZhihua Liu, Robin K Meray, Tom N Grammatopoulos, et al.
The American Journal of Pathology|July 25, 2009
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synucleinWai Haung Yu, Beatriz Dorado, Helen Yvette Figueroa, et al.
Cellular and Molecular Life Sciences : CMLS|January 11, 2020
Correction to: Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDACAmandine Rovini, Philip A Gurnev, Alexandra Beilina, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
A xeno-free protocol for rapid differentiation of human iPSC-derived microglia from the KOLF2.1J reference lineNélio A J Oliveira, Katherine R Lewkowicz, Patricia A Clow, et al.
Plos Biology|February 4, 2010
PINK1 is selectively stabilized on impaired mitochondria to activate ParkinDerek P Narendra, Seok Min Jin, Atsushi Tanaka, et al.
Neuroscience Letters|January 17, 2009
Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson diseaseJeff Blackinton, Ravindran Kumaran, Marcel P van der Brug, et al.
Neuroscience Letters|January 25, 2005
Unaltered alpha-synuclein blood levels in juvenile Parkinsonism with a parkin exon 4 deletionDavid W Miller, Anthony Crawley, Katrina Gwinn-Hardy, et al.
The Biochemical Journal|March 22, 2017
The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Iakov N Rudenko, Alice Kaganovich, Rebekah G Langston, et al.
Pageof 34